Albert Alé
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Multiple Myeloma Research and Treatments 6
-
- Ubiquitin and proteasome pathways 4
- Co-authors
- Xavier Navarro (8 shared papers)Esther Udina (7 shared papers)Jordi Bruna (6 shared papers)Johan Monbaliu (2 shared papers)Lee Silverman (1 shared paper)J Vilches (1 shared paper)Dongsheng Cai (2 shared papers)Isaac Francos-Quijorna (1 shared paper)
- Journals
- Experimental Neurology (2 papers)NeuroToxicology (2 papers)Frontiers in Cellular Neuroscience (1 paper)European Journal of Neuroscience (1 paper)Journal of the Peripheral Nervous System (1 paper)
- Partner nations
- SpainUnited StatesGreece
In The Last Decade
Albert Alé
10 papers receiving 332 citations
Peers
Comparison fields: 5 of 55
- Hematology 113
- Oncology 143
- Neurology 56
- Cellular and Molecular Neuroscience 49
- Endocrine and Autonomic Systems 17
Countries citing papers authored by Albert Alé
This map shows the geographic impact of Albert Alé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Alé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Alé more than expected).
Fields of papers citing papers by Albert Alé
This network shows the impact of papers produced by Albert Alé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Alé. The network helps show where Albert Alé may publish in the future.
Co-authors
The 22 scholars most cited alongside Albert Alé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 83 | |
| 2 | 2014 | 45 | |
| 3 | 2014 | 45 | |
| 4 | 2014 | 34 | |
| 5 | 2015 | 33 | |
| 6 | 2016 | 22 | |
| 7 | 2016 | 22 | |
| 8 | 2015 | 19 | |
| 9 | 2011 | 19 | |
| 10 | 2016 | 14 |
About Albert Alé
Albert Alé is a scholar working on Hematology, Molecular Biology, Oncology, Cellular and Molecular Neuroscience and Neurology, having authored 10 papers that have together received 336 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Treatment and Pharmacology (4 papers), Nerve injury and regeneration (2 papers), Neurogenesis and neuroplasticity mechanisms (1 paper), NF-κB Signaling Pathways (1 paper), Amyotrophic Lateral Sclerosis Research (1 paper) and Circadian rhythm and melatonin (1 paper). The work is most often cited by research in Hematology (113 citations), Oncology (143 citations), Neurology (56 citations), Cellular and Molecular Neuroscience (49 citations) and Endocrine and Autonomic Systems (17 citations). Albert Alé has collaborated with scholars based in Spain, United States and Greece. Frequent co-authors include Xavier Navarro, Esther Udina, Jordi Bruna, Johan Monbaliu, Lee Silverman, J Vilches, Dongsheng Cai, Isaac Francos-Quijorna, Laura Mòdol and Renzo Mancuso. Their work appears in journals such as Experimental Neurology, NeuroToxicology, Frontiers in Cellular Neuroscience, European Journal of Neuroscience and Journal of the Peripheral Nervous System.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.